These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 27521033)

  • 41. Feasibility of combined operation and perioperative intensity-modulated brachytherapy of advanced/recurrent malignancies involving the skull base.
    Strege RJ; Kovács G; Maune S; Holland D; Niehoff P; Eichmann T; Mehdorn HM
    Strahlenther Onkol; 2005 Feb; 181(2):97-107. PubMed ID: 15702298
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Image-guided adaptive brachytherapy in the treatment of patients with cervix cancer].
    Haie-Meder C; Thomas L; Barillot I; Pommier P; Nickers P
    Cancer Radiother; 2013 Apr; 17(2):98-105. PubMed ID: 23597622
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Correlation between the treated volume, the GTV and the CTV at the time of brachytherapy and the histopathologic findings in 33 patients with operable cervix carcinoma.
    Muschitz S; Petrow P; Briot E; Petit C; De Crevoisier R; Duvillard P; Morice P; Haie-Meder C
    Radiother Oncol; 2004 Nov; 73(2):187-94. PubMed ID: 15542166
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Management of locally advanced anal canal carcinoma with modulated arctherapy and concurrent chemotherapy].
    Troussier I; Huguet F; Servagi-Vernat S; Benahim C; Khalifa J; Darmon I; Ortholan C; Krebs L; Dejean C; Fenoglietto P; Vieillot S; Bensadoun RJ; Thariat J
    Cancer Radiother; 2015 Apr; 19(2):127-38. PubMed ID: 25770884
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Target volume definition for intensity-modulated radiotherapy after induction chemotherapy and patterns of treatment failure after sequential chemoradiotherapy in locoregionally advanced oropharyngeal squamous cell carcinoma.
    Loo SW; Geropantas K; Wilson P; Martin WM; Roques TW
    Clin Oncol (R Coll Radiol); 2013 Mar; 25(3):162-70. PubMed ID: 22906546
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influence of dose point and inverse optimization on interstitial cervical and oropharyngeal carcinoma brachytherapy.
    Ahmad F; Aletti P; Charra-Brunaud C; Van der Laarse R; Lapeyre M; Hoffstetter S; Peiffert D; Nöel A
    Radiother Oncol; 2004 Dec; 73(3):331-7. PubMed ID: 15588879
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Endobronchial brachytherapy: state of the art in 2013].
    Derhem N; Sabila H; Mornex F
    Cancer Radiother; 2013 Apr; 17(2):162-5. PubMed ID: 23465785
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Altered and conventional fractionated radiotherapy in locoregional control and survival of patients with squamous cell carcinoma of the larynx, oropharynx, and hypopharynx.
    Krstevska V; Crvenkova S
    Croat Med J; 2006 Feb; 47(1):42-52. PubMed ID: 16489696
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Volumetric-modulated arc therapy (RapidArc) vs. conventional fixed-field intensity-modulated radiotherapy for ¹⁸F-FDG-PET-guided dose escalation in oropharyngeal cancer: a planning study.
    Teoh M; Beveridge S; Wood K; Whitaker S; Adams E; Rickard D; Jordan T; Nisbet A; Clark CH
    Med Dosim; 2013; 38(1):18-24. PubMed ID: 22841937
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Carcinoma of the oropharynx extended to the base of the tongue: radiosurgical treatment with intraoperative radiotherapy].
    Schmitt T; Prades J; Pinto N; Puel G; Barbet N; Calloc'h F
    Bull Cancer Radiother; 1996; 83(2):79-85. PubMed ID: 8688223
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Hepatic tumors and radiotherapy].
    Rio E; Mornex F; Peiffert D; Huertas A
    Cancer Radiother; 2016 Sep; 20 Suppl():S174-8. PubMed ID: 27521035
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Target volumes in radiotherapy - head and neck tumors intensity - modulated radiation therapy (IMRT) of nasopharyngeal carcinoma: practical aspects in the delineation of target volumes and organs at risk].
    Marcy PY; Zhu Y; Bensadoun RJ
    Cancer Radiother; 2005 Jun; 9(4):240-50. PubMed ID: 16081022
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Three-dimensional conformal brachytherapy boost in locally recurrent or residual cervical carcinoma: does it impact clinical outcome?
    Bansal V; Kumar G; Bhutani R; Venkadamanickam G; Sharma SK; Sigamani AK; Shekhon R; Rawal SK
    J Obstet Gynaecol Res; 2013 Jan; 39(1):264-71. PubMed ID: 22640182
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predictors of toxicity after image-guided high-dose-rate interstitial brachytherapy for gynecologic cancer.
    Lee LJ; Viswanathan AN
    Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1192-7. PubMed ID: 22592049
    [TBL] [Abstract][Full Text] [Related]  

  • 55. IMRT for image-guided single vocal cord irradiation.
    Osman SO; Astreinidou E; de Boer HC; Keskin-Cambay F; Breedveld S; Voet P; Al-Mamgani A; Heijmen BJ; Levendag PC
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):989-97. PubMed ID: 21300449
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Common chapter dedicated to taking care about the preparation of irradiation of head and neck carcinoma].
    Maingon P; Giraud P; Pointreau Y
    Cancer Radiother; 2016 Sep; 20 Suppl():S96-8. PubMed ID: 27521034
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
    Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
    Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Current radiation therapy management issues in oral cavity cancer.
    Ballonoff A; Chen C; Raben D
    Otolaryngol Clin North Am; 2006 Apr; 39(2):365-80. PubMed ID: 16580917
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metabolic imaging in non-small-cell lung cancer radiotherapy.
    Geets X; Sterpin E; Wanet M; Di Perri D; Lee J
    Cancer Radiother; 2014 Oct; 18(5-6):402-5. PubMed ID: 25179249
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [What is the level of evidence of new techniques in prostate cancer radiotherapy?].
    Khadige M; Peiffert D; Supiot S
    Cancer Radiother; 2014 Oct; 18(5-6):501-8. PubMed ID: 25192625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.